[Effect of prostaglandins on cellular immune response in mice with melanoma B16].
D015064:16,16-Dimethylprostaglandin E2 / Q000627:therapeutic use*; D000818:Animals; D005260:Female; D007111:Immunity, Cellular; D007153:Immunologic Deficiency Syndromes / Q000188:drug therapy* / Q000209:etiology; D008545:Melanoma / Q000150:complications / Q000188:drug therapy* / Q000276:immunology; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy; D011459:Prostaglandins E, Synthetic / Q000627:therapeutic use*; D013997:Time Factors
D011459:Prostaglandins E, Synthetic; D015064:16,16-Dimethylprostaglandin E2
Effetti delle prostaglandine sulla risposta immunitaria cellulare in topi portatori di melanoma B 16.